Skip to content

Study · Animal study (in vivo) · mouse · 1995

1 result

Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition.

Tan CK, Podila PV, Taylor JE, Nagorney DM, Wiseman GA, Gores GJ, LaRusso NF

Gastroenterology1 Jun 1995Cited by 42 (Europe PMC)

PMID7768398 (opens in a new tab)DOI10.1016/0016-5085(95)90157-4 (opens in a new tab)PepBankPUB-07768398
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In athymic mice implanted with human cholangiocarcinoma cells, lanreotide inhibited tumor growth.

    In plain wordsIn mice implanted with human cholangiocarcinoma cells, lanreotide inhibited tumor growth.

    Peptide
    Lanreotide
    Outcome
    DecreaseTumor growth
    Study

    micen: not reported in source

    Athymic mice implanted with human cholangiocarcinoma cells
    Outcome group
    Tumor growth · Cancer
    Studied dose
    Dose not stated

    Source sentences

    Summary
    and inhibition in vivo of tumor growth in athymic mice implanted with human cholangiocarcinoma cells and treated with lanreotide, another SS analogue.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:36 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.